Intelligence · Patents
Patents expiring in 2030
Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.
- Patents
- 880
Quick answer
880 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7709643
Synthesis of sodium narcistatin and related compounds
granted -
US 7709609
Tumor suppressor gene, p47ING3
granted -
US 7709515
Compositions comprising ether compounds and pharmaceutical uses therefor
granted -
US 7709517
Diarylhydantoin compounds
granted -
US 7709007
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
granted -
US 7709625
Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy
granted -
US 7709190
Influenza A virus vaccines and inhibitors
granted -
US 7709482
Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
granted -
US 7713721
Methods and composition for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs
granted -
US 7713987
Pyrimidine-2,4-diamines and their uses
granted -
US 7713526
Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
granted -
US 7713934
Thrombin peptide derivatives
granted -
US 7713925
Syndecans and angiogenesis
granted -
US 7713927
Antimicrobial peptides
granted -
US 7714009
Nitrogen-containing fused heterocyclic compounds
granted -
US 7713931
Cross-linked glycopeptide-cephalosporin antibiotics
granted -
US 7713983
Quinazolines useful as modulators of ion channels
granted -
US 7713995
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
granted -
US 7714014
Targeting GLI proteins in human cancer by small molecules
granted -
US 7714109
Combinations and kits for cancer treatment using selected antibodies to aminophospholipids
granted -
US 7714114
Conjugates of an EPO moiety and a polymer
granted -
US 7714137
Pyridyl substituted heterocycles useful for treating or preventing HCV infection
granted -
US 7713529
Methods for treating and preventing infectious disease
granted -
US 7714088
Poly(ethylene glycol) derivatives with proximal reactive groups
granted -
US 7713973
Kinase inhibitors
granted -
US 7713939
Illudin analogs useful as antitumor agents
granted -
US 7713710
Isolation and use of solid tumor stem cells
granted -
US 7714007
Method of alleviating chronic pain via peripheral glutaminase regulation
granted -
US 7718670
Quinuclidine amide derivatives
granted -
US 7718170
Alkaline phosphatase compositions to reduce skin cancer
granted -
US 7717728
Electrical Connector
granted -
US 7718387
Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
granted -
US 7718183
Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species
granted -
US 7718386
Methods for the diagnosis of diabetes
granted -
US 7718629
Compositions and methods for inhibiting expression of Eg5 gene
granted -
US 7718612
Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
granted -
US 7718600
IAP binding compounds
granted -
US 7718618
Human cathelicidin antimicrobial peptides
granted -
US 7718610
Retrocyclins: antiviral and antimicrobial peptides
granted -
US 7718160
Radiolabeled compounds and liposomes and their method of making and using same
granted -
US 7718769
Tri-peptide hepatitis C serine protease inhibitors
granted -
US 7718424
AAV4 vector and uses thereof
granted -
US 7718658
Quinazolines useful as modulators of ion channels
granted -
US 7718684
Methods and materials for assessing prostate cancer therapies and compounds
granted -
US 7718196
Rapamycin-resistant T cells and therapeutic uses thereof
granted -
US 7718428
Myeloid colony stimulating factor and uses thereof
granted -
US 7718781
Hydroxypyridonate and hydroxypyrimidinone chelating agents
granted -
US 7718798
Indole compound
granted
Frequently asked questions
How many pharma patents expire in 2030?
880 published patents in our USPTO index have expiration dates falling in calendar year 2030.